Singapore: WuXi PharmaTech, research and technology platform company serving the pharmaceutical, biotechnology, and medi...
Singapore: Gilead Sciences and WuXi PharmaTech have entered into a strategic partnership to conduct analytical and stabi...
The conventional view of contract research organizations (CROs) bears little relationship with the way in which they wer...
Singapore: PAREXEL and PAREXEL Academy hosted a Key Opinion Leaders (KOL) roundtable in Taipei, Taiwan on November 23, 2...
Singapore: Australian company Cogstate has earned overall revenue of $6.14 million and a net loss of $0.49 million in th...
Singapore: Taiwan-based ScinoPharm (Changshu) Pharmaceuticals and Shanghai-based Sundia MediTech entered in a strategic ...
Singapore: Monitoring a clinical study is an important challenge faced by local as well as global CRO where the sponsor ...
Singapore: AMRI has completed the acquisition of Cedarburg Pharmaceuticals, a contract developer and manufacturer of tec...
Singapore: BioClinica, a global provider of clinical trial management services, has merged with CoreLab Partners as an i...
Singapore: Leading global contract research giant Quintiles has cited a challenging external business environment as the...
Singapore: Riken has launched a pilot study to assess the safety and feasibility of the transplantation of autologous in...
Singapore: In a study that analysed reports from large clinical trials (more than 500 participants), registered on Clini...
Growth of the biotech industry in Singapore over the last 10 years has, in a number of measures, outpa...
Singapore: A recent report released by RnRMarketResearch.com has analyzed the Global Biochips Industry and forecasted th...
Singapore: Pharma and biotech R&D service provider, WuXi PharmaTech, has acquired XenoBiotic Laboratories, a contrac...
Singapore: Charles River has acquired Brass, a Singapore-based microbiology subcontract test laboratory specializing in ...
Singapore: Australia's National Health and Medical Research Council (NHMRC) has taken up the task of implementing initia...
Singapore: China bioscience service provider, WuXi PharmaTech, has appointed Mr William Robert Keller as an independent ...
